Oxford Nanopore Technologies (LON:ONT) Lowered to Buy Rating by Citigroup

Oxford Nanopore Technologies (LON:ONT) was downgraded by analysts at Citigroup to a “buy” rating in a research note issued to investors on Friday,London Stock Exchange reports.

Separately, Royal Bank Of Canada reiterated an “outperform” rating and issued a GBX 225 price target on shares of Oxford Nanopore Technologies in a research note on Tuesday, May 26th. Four research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of GBX 218.60.

Oxford Nanopore Technologies Stock Performance

Shares of Oxford Nanopore Technologies stock opened at GBX 120.10 on Friday. Oxford Nanopore Technologies has a 12 month low of GBX 104 and a 12 month high of GBX 224.80. The firm has a market capitalization of £1.17 billion, a P/E ratio of -7.95 and a beta of 0.92. The company has a current ratio of 3.56, a quick ratio of 6.01 and a debt-to-equity ratio of 8.96. The business has a fifty day simple moving average of GBX 123.09 and a two-hundred day simple moving average of GBX 128.17.

Insider Buying and Selling at Oxford Nanopore Technologies

In related news, insider Nick Keher purchased 22,018 shares of the business’s stock in a transaction that occurred on Monday, May 11th. The shares were bought at an average price of GBX 113 per share, for a total transaction of £24,880.34. In the last quarter, insiders purchased 22,799 shares of company stock valued at $2,578,133. Corporate insiders own 2.54% of the company’s stock.

About Oxford Nanopore Technologies

Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.